Martin Obermeier

1.2k total citations
48 papers, 512 citations indexed

About

Martin Obermeier is a scholar working on Infectious Diseases, Virology and Hepatology. According to data from OpenAlex, Martin Obermeier has authored 48 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 16 papers in Virology and 15 papers in Hepatology. Recurrent topics in Martin Obermeier's work include HIV/AIDS drug development and treatment (21 papers), HIV Research and Treatment (15 papers) and Hepatitis C virus research (14 papers). Martin Obermeier is often cited by papers focused on HIV/AIDS drug development and treatment (21 papers), HIV Research and Treatment (15 papers) and Hepatitis C virus research (14 papers). Martin Obermeier collaborates with scholars based in Germany, Slovakia and Austria. Martin Obermeier's co-authors include Birgit Vogel‐Heuser, Rolf Kaiser, Steven Braun, Maria Neumann‐Fraune, Hauke Walter, Thomas Berg, Thomas Lengauer, Robert Ehret, Eva Heger and Jori Symons and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Martin Obermeier

43 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Obermeier Germany 14 225 221 195 139 70 48 512
David Friedrich Germany 14 84 0.4× 13 0.1× 262 1.3× 115 0.8× 44 0.6× 39 489
Yixin He China 8 138 0.6× 36 0.2× 164 0.8× 41 0.3× 50 0.7× 17 287
Herbert Stekel Austria 12 123 0.5× 62 0.3× 102 0.5× 97 0.7× 2 0.0× 24 368
Jeerayut Chaijaruwanich Thailand 11 92 0.4× 15 0.1× 36 0.2× 22 0.2× 16 0.2× 36 538
Herwig Van Marck Belgium 15 390 1.7× 126 0.6× 148 0.8× 350 2.5× 29 657
Mojgan Haddad United States 16 178 0.8× 50 0.2× 71 0.4× 226 1.6× 32 628
Steven F. Baker United States 21 207 0.9× 10 0.0× 681 3.5× 23 0.2× 70 1.0× 34 1.2k
Nathalie Verdière France 12 83 0.4× 45 0.2× 81 0.4× 44 0.3× 1 0.0× 51 356
Laurence Rodrigues do Amaral Brazil 14 78 0.3× 17 0.1× 148 0.8× 27 0.2× 3 0.0× 62 519

Countries citing papers authored by Martin Obermeier

Since Specialization
Citations

This map shows the geographic impact of Martin Obermeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Obermeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Obermeier more than expected).

Fields of papers citing papers by Martin Obermeier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Obermeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Obermeier. The network helps show where Martin Obermeier may publish in the future.

Co-authorship network of co-authors of Martin Obermeier

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Obermeier. A scholar is included among the top collaborators of Martin Obermeier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Obermeier. Martin Obermeier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kammel, Martin, Christoph Buchta, Stephan W. Aberle, et al.. (2025). Detection of H5N1 clade 2.3.4.4b in external quality assessment programmes: a pandemic preparedness initiative. The Lancet Microbe. 6(12). 101231–101231. 1 indexed citations
2.
Charpentier, Charlotte, Quentin Le Hingrat, Rolf Kaiser, et al.. (2025). HIV-2 EU—Supporting Standardized HIV-2 Drug Resistance Interpretation: An Update. Clinical Infectious Diseases. 81(3). 539–542. 1 indexed citations
3.
Obermeier, Martin, Oliver Heese, Nir Cohen, et al.. (2025). Non-antifungal medications administered during fungal infections drive drug tolerance and resistance in Candida albicans. Journal of Medical Microbiology. 74(7).
4.
Valiente, Esmeralda, A. Kummrow, Martin Kammel, et al.. (2024). Droplet digital PCR for accurate quantification and detection of outbreak pathogens. Clinica Chimica Acta. 558. 119103–119103.
5.
Lübke, Nadine, Andreas Walker, Martin Obermeier, et al.. (2024). Real-world performance of the NeuMoDx™ HCV Quant Test for quantification of hepatitis C virus (HCV)-RNA. Journal of Virological Methods. 327. 114937–114937.
6.
Singer, Eugenia, Friederike Bachmann, Fabian Halleck, et al.. (2023). Plasma NGAL levels in stable kidney transplant recipients and the risk of allograft loss. Nephrology Dialysis Transplantation. 39(3). 483–495. 2 indexed citations
7.
Kaiser, Patricia, Hans‐Peter Grunert, Janine Michel, et al.. (2023). Results of the first German external quality assessment scheme for the detection of monkeypox virus DNA. PLoS ONE. 18(4). e0285203–e0285203. 1 indexed citations
8.
Hommel, Matthias, Oliver Miera, Felix Schoenrath, et al.. (2021). Preventing SARS-CoV-2 In-Hospital Infections in Cardiovascular Patients and Medical Staff: An Observational Study From the German Heart Center Berlin. Frontiers in Medicine. 7. 616648–616648.
9.
Ehret, Robert, et al.. (2021). Clinical evaluation of the automated Abbott RealTime SARS-CoV-2, Alinity m SARS-CoV-2, and Alinity m Resp-4-Plex assays. Journal of Virological Methods. 299. 114338–114338. 6 indexed citations
10.
Heger, Eva, Alexander Thielen, Martin Obermeier, et al.. (2021). Adapting the geno2pheno[coreceptor] tool to HIV-1 subtype CRF01_AE by phenotypic validation using clinical isolates from South-East Asia. Journal of Clinical Virology. 136. 104755–104755. 1 indexed citations
11.
Hauser, Andrea, Daniel Schmidt, Barbara Gunsenheimer‐Bartmeyer, et al.. (2020). Comparison of two immunoassays for concurrent detection of HCV antigen and antibodies among HIV/HCV co-infected patients in dried serum/plasma spots. Journal of Virological Methods. 279. 113839–113839. 1 indexed citations
12.
Walker, Andreas, Nadine Lübke, Martin Obermeier, et al.. (2017). Detection of a genetic footprint of the sofosbuvir resistance-associated substitution S282T after HCV treatment failure. Virology Journal. 14(1). 106–106. 14 indexed citations
13.
Kalaghatgi, Prabhav, Elena Knops, Daniel Rupp, et al.. (2016). Geno2pheno[HCV] – A Web-based Interpretation System to Support Hepatitis C Treatment Decisions in the Era of Direct-Acting Antiviral Agents. PLoS ONE. 11(5). e0155869–e0155869. 80 indexed citations
14.
Ingiliz, Patrick, Christoph Mayr, Martin Obermeier, et al.. (2016). Persisting hepatitis E virus infection leading to liver cirrhosis despite recovery of the immune system in an HIV-infected patient. Clinics and Research in Hepatology and Gastroenterology. 40(3). e23–e25. 24 indexed citations
15.
Ehret, Robert, Hauke Walter, Patrick Ingiliz, et al.. (2014). Safety analysis of raltegravir/truvada regimen in HIV/HCV co‐infected patients without switchback after HCV treatment. Journal of the International AIDS Society. 17(4S3). 19644–19644. 1 indexed citations
16.
Neumann‐Fraune, Maria, et al.. (2014). Hepatitis B Virus Drug Resistance Tools: One Sequence, Two Predictions. Intervirology. 57(3-4). 232–236. 19 indexed citations
17.
Obermeier, Martin, et al.. (2014). Resistance remains a problem in treatment failure. Journal of the International AIDS Society. 17(4S3). 19756–19756. 3 indexed citations
18.
Obermeier, Martin, Jori Symons, & Annemarie M. J. Wensing. (2012). HIV population genotypic tropism testing and its clinical significance. Current Opinion in HIV and AIDS. 7(5). 470–477. 23 indexed citations
19.
Obermeier, Martin, Alejandro Pironti, Thomas Berg, et al.. (2012). HIV-GRADE: A Publicly Available, Rules-Based Drug Resistance Interpretation Algorithm Integrating Bioinformatic Knowledge. Intervirology. 55(2). 102–107. 32 indexed citations
20.
Verheyen, Jens, Maria Neumann‐Fraune, Thomas Berg, Rolf Kaiser, & Martin Obermeier. (2012). The detection of HBsAg mutants expressed in vitro using two different quantitative HBsAg assays. Journal of Clinical Virology. 54(3). 279–281. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Friedrich Breakdown of academic impact, for papers by Yixin He Breakdown of academic impact, for papers by Herbert Stekel Breakdown of academic impact, for papers by Jeerayut Chaijaruwanich Breakdown of academic impact, for papers by Herwig Van Marck Breakdown of academic impact, for papers by Mojgan Haddad Breakdown of academic impact, for papers by Steven F. Baker Breakdown of academic impact, for papers by Nathalie Verdière Breakdown of academic impact, for papers by Laurence Rodrigues do Amaral
Rankless by CCL
2026